FYB1
Basic information
Region (hg38): 5:39105252-39274528
Previous symbols: [ "FYB" ]
Links
Phenotypes
GenCC
Source:
- thrombocytopenia 3 (Strong), mode of inheritance: AR
- thrombocytopenia 3 (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Thrombocytopenia 3 | AR | Hematologic | Individuals have been described with bleeding tendency, and awareness may allow early diagnosis, preventive measures, and early and aggressive treatment of bleeding episodes | Hematologic | 23650215; 25516138; 25876182 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FYB1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 13 | ||||
missense | 56 | 65 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 36 | 36 | ||||
Total | 0 | 0 | 56 | 15 | 43 |
Variants in FYB1
This is a list of pathogenic ClinVar variants found in the FYB1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-39107251-T-A | Benign (Jun 18, 2021) | |||
5-39107451-T-A | not specified | Uncertain significance (Feb 10, 2022) | ||
5-39107465-C-T | not specified | Uncertain significance (Jun 09, 2022) | ||
5-39107781-A-G | Benign (Nov 11, 2018) | |||
5-39108207-A-G | Benign (Jun 18, 2021) | |||
5-39108220-A-G | Benign (Nov 11, 2018) | |||
5-39108243-C-T | not specified | Uncertain significance (Jun 07, 2023) | ||
5-39110312-A-T | Benign (Jun 20, 2021) | |||
5-39110357-T-G | Thrombocytopenia 3 | Uncertain significance (Apr 09, 2018) | ||
5-39110379-G-A | FYB1-related disorder | Likely benign (May 23, 2019) | ||
5-39118886-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
5-39118901-C-A | not specified | Uncertain significance (Dec 19, 2022) | ||
5-39118918-G-A | not specified | Uncertain significance (Jul 12, 2023) | ||
5-39118925-T-A | not specified | Uncertain significance (Dec 18, 2023) | ||
5-39118981-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
5-39118985-T-C | not specified | Uncertain significance (Jul 26, 2022) | ||
5-39118987-A-G | not specified | Uncertain significance (May 08, 2024) | ||
5-39119120-T-G | Benign (Nov 11, 2018) | |||
5-39119142-A-G | Benign (Jun 21, 2021) | |||
5-39119459-T-C | Benign (Nov 11, 2018) | |||
5-39119621-C-A | Benign (Nov 11, 2018) | |||
5-39122338-C-A | not specified | Uncertain significance (Jul 14, 2023) | ||
5-39122399-A-G | not specified | Uncertain significance (Jul 27, 2022) | ||
5-39124256-A-G | not specified | Likely benign (May 04, 2022) | ||
5-39124406-C-T | Benign (Nov 11, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FYB1 | protein_coding | protein_coding | ENST00000540520 | 19 | 169293 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.238 | 0.762 | 124678 | 0 | 18 | 124696 | 0.0000722 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.436 | 437 | 412 | 1.06 | 0.0000204 | 5465 |
Missense in Polyphen | 98 | 102.95 | 0.95189 | 1407 | ||
Synonymous | -0.991 | 172 | 156 | 1.10 | 0.00000873 | 1585 |
Loss of Function | 4.37 | 9 | 38.1 | 0.236 | 0.00000181 | 564 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000223 | 0.000223 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000117 | 0.000115 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as an adapter protein of the FYN and LCP2 signaling cascades in T-cells. Modulates the expression of interleukin-2 (IL-2). Involved in platelet activation. Prevents the degradation of SKAP1 and SKAP2. May play a role in linking T-cell signaling to remodeling of the actin cytoskeleton. {ECO:0000269|PubMed:10747096, ECO:0000269|PubMed:15849195, ECO:0000269|PubMed:16980616}.;
- Disease
- DISEASE: Thrombocytopenia 3 (THC3) [MIM:273900]: Thrombocytopenia is defined by a decrease in the number of platelets in circulating blood, resulting in the potential for increased bleeding and decreased ability for clotting. THC3 is an autosomal recessive form characterized by onset in infancy. {ECO:0000269|PubMed:25516138, ECO:0000269|PubMed:25876182}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Rap1 signaling pathway - Homo sapiens (human);T-Cell antigen Receptor (TCR) Signaling Pathway;Generation of second messenger molecules;TCR signaling;TCR;Immune System;Adaptive Immune System;Signal regulatory protein family interactions;Cell-Cell communication;TCR signaling in naïve CD4+ T cells
(Consensus)
Recessive Scores
- pRec
- 0.197
Intolerance Scores
- loftool
- rvis_EVS
- -0.18
- rvis_percentile_EVS
- 40.56
Haploinsufficiency Scores
- pHI
- 0.0744
- hipred
- Y
- hipred_score
- 0.655
- ghis
- 0.506
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Fyb
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; hematopoietic system phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein phosphorylation;NLS-bearing protein import into nucleus;immune response;signal transduction;integrin-mediated signaling pathway;biological_process;intracellular signal transduction;T cell receptor signaling pathway;protein localization to plasma membrane
- Cellular component
- nucleus;cytosol;plasma membrane;actin cytoskeleton;cell junction
- Molecular function
- signaling receptor binding;protein binding;lipid binding;protein-containing complex binding